Crestwood Advisors Group LLC Trims Position in Xylem Inc. (NYSE:XYL)

Crestwood Advisors Group LLC lowered its position in Xylem Inc. (NYSE:XYLFree Report) by 0.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 477,338 shares of the industrial products company’s stock after selling 741 shares during the quarter. Xylem comprises about 1.2% of Crestwood Advisors Group LLC’s holdings, making the stock its 24th biggest holding. Crestwood Advisors Group LLC owned approximately 0.20% of Xylem worth $64,455,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of XYL. Catalyst Capital Advisors LLC increased its stake in Xylem by 226.0% during the third quarter. Catalyst Capital Advisors LLC now owns 339 shares of the industrial products company’s stock worth $46,000 after acquiring an additional 235 shares during the last quarter. Hazlett Burt & Watson Inc. raised its holdings in Xylem by 92.4% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 656 shares of the industrial products company’s stock valued at $88,000 after buying an additional 315 shares during the period. Impax Asset Management Group plc lifted its position in Xylem by 1.0% in the third quarter. Impax Asset Management Group plc now owns 1,677,816 shares of the industrial products company’s stock valued at $226,555,000 after buying an additional 15,825 shares during the last quarter. Quintet Private Bank Europe S.A. lifted its position in Xylem by 28.0% in the third quarter. Quintet Private Bank Europe S.A. now owns 203,262 shares of the industrial products company’s stock valued at $27,446,000 after buying an additional 44,414 shares during the last quarter. Finally, QRG Capital Management Inc. boosted its stake in Xylem by 12.2% during the third quarter. QRG Capital Management Inc. now owns 15,281 shares of the industrial products company’s stock worth $2,063,000 after buying an additional 1,665 shares during the period. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Stock Up 0.7 %

Xylem stock traded up $0.81 during trading on Tuesday, reaching $121.65. The stock had a trading volume of 106,716 shares, compared to its average volume of 1,184,530. Xylem Inc. has a 52-week low of $95.35 and a 52-week high of $146.08. The business has a 50 day moving average price of $132.78 and a 200 day moving average price of $135.24. The company has a quick ratio of 1.42, a current ratio of 1.96 and a debt-to-equity ratio of 0.19. The stock has a market cap of $29.55 billion, a PE ratio of 35.33, a P/E/G ratio of 2.12 and a beta of 1.05.

Xylem (NYSE:XYLGet Free Report) last issued its earnings results on Thursday, October 31st. The industrial products company reported $1.11 EPS for the quarter, hitting analysts’ consensus estimates of $1.11. The firm had revenue of $2.10 billion during the quarter, compared to the consensus estimate of $2.17 billion. Xylem had a net margin of 9.85% and a return on equity of 9.61%. The company’s revenue was up .2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.99 earnings per share. On average, analysts predict that Xylem Inc. will post 4.23 EPS for the current year.

Xylem Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 26th. Investors of record on Thursday, August 29th were issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 1.18%. The ex-dividend date of this dividend was Thursday, August 29th. Xylem’s dividend payout ratio (DPR) is 42.11%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the stock. UBS Group initiated coverage on shares of Xylem in a report on Tuesday, August 13th. They issued a “buy” rating and a $165.00 price objective on the stock. TD Cowen restated a “hold” rating and set a $138.00 price target on shares of Xylem in a research note on Tuesday, September 3rd. Stifel Nicolaus lifted their price objective on Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research note on Wednesday, July 31st. Royal Bank of Canada decreased their target price on Xylem from $163.00 to $162.00 and set an “outperform” rating on the stock in a research note on Friday. Finally, Robert W. Baird lowered their target price on Xylem from $175.00 to $154.00 and set an “outperform” rating for the company in a report on Friday. Four investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat, Xylem presently has a consensus rating of “Moderate Buy” and an average price target of $148.25.

Get Our Latest Stock Report on Xylem

About Xylem

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.